Cryptococcosis Market Research Report Forecast to 2024
Publisher reveals in a recently released market intelligence report that leading players from the global cryptococcosis market are likely to participate in a wave of mergers and acquisitions in all key regions of the market over the coming years. Business conglomerates have significant investments in the recent past to bring to fruition their research and development efforts for new drugs and are interested in expanding their distribution chain to broader regions. The global cryptococcosis market was calculated to reach US$4.31 bn by the end of 2016, and is projected to reach US$6.2 bn by the end of 2024, after expanding at a CAGR of 4.8% from 2016 to 2024.“The key factor currently working for the growth of the global cryptococcosis market is the growing count of patients being infected by the disease. Although previously classified as a rarely occurring illness, cryptococcosis is seen to be growing in count across the globe and the healthcare industry is aware of this. The CDC had stated earlier that close to a million new cases of cryptococcosis are being spotted globally each year and are the cause of 625,000 deaths. The current gold standard for cryptococcosis treatment – Amphotericin B plus oral flucytosin – is at the forefront of the demand so far. The scope for other existing and pipeline treatments is also very high,” states a TMR analyst.
Aiding the growth rate of the global cryptococcosis market are multiple governments highly interested in eradicating the disease from their nations. The increasingly powerful efforts put in by governments are allowing players in the market to invest better into advanced treatment options and the development on pipeline drugs, as well as the better distribution of existing ones. The count of cryptococcosis patients is also directly linked to the diagnosis of HIV, which is another growing count in the world. The increasing number of HIV patients are shown to be highly likely to develop cryptococcosis during late-stage HIV infection, further pushing the demand for cryptococcosis treatment.
Request to view Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=14984
One of the key factors holding the global cryptococcosis market back currently is the very high mortality rate among cryptococcosis patients. Pneumocystis pneumonia and cryptococcal meningitis are the two greater fungal infections that lead to death in the world. The mortality rate of HIV patients who get diagnosed with cryptococcosis is extremely close to 100%. This gives a very minor scope of development of existing and pipeline drugs as it can cripple the overall testing phase. The market is also expected to face severe degradation of quality due to the imminent patent expirations and the consequent surge of generics. Their extremely low pricing will allow them to take up large demand volumes in all regions, disallowing branded manufacturers from generating enough to invest in further research and development.
“The future of the global cryptococcosis market can lie in the installation of integrated facilities in the regions where penetration potential is currently at an all-time high. These integrated facilities can allow manufacturers in the pharmaceutical industry to reduce operating costs and increase production speeds, allowing them to maintain a competitive edge against rivals,” adds the analyst.
Request to Download TOC of the Report: http://www.transparencymarketresearch.com/report-toc/14984
The highly fragmented global cryptococcosis market is being pioneered by only a handful of players based in developed regions of the world. Pfizer, Inc., Valeant Pharmaceuticals, Inc., Bristol-Myers Squibb Company, and Janssen Biotech, Inc. had collectively held a share of 41% in the global cryptococcosis market in terms of value, for 2015. Their dominance in the market was marked by factors such as operating stronghold in developed economies where the demand and awareness are high, better brand name recognition, and higher investments in research and development.
Global Cryptococcosis Market Report is available @ US$ 5795 : http://www.transparencymarketresearch.com/checkout.php?rep_id=14984<ype=S
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cryptococcosis Market Research Report Forecast to 2024 here
News-ID: 746246 • Views: …
More Releases from Transparency Market Research
Teflon Heat Exchanger Market Growth Forecast 2034: From USD 1.1 Billion to USD 2 …
The global Teflon heat exchanger market is poised for substantial growth, driven by increasing focus on energy efficiency and sustainability across various industries. Valued at US$ 1.1 billion in 2023, the market is projected to grow at a CAGR of 7.7%, reaching US$ 2.5 billion by 2034. This growth trajectory underscores the critical role of Teflon heat exchangers in optimizing energy usage and reducing environmental impact.
Download Sample Report Copy Here:…
Alternative Energy Market Growth Forecast 2034: From USD 940.4 Billion to USD 3. …
The global alternative energy market is poised for substantial growth, driven by a shift towards sustainable practices and technological advancements. Valued at US$ 940.4 billion in 2023, the market is projected to expand at a robust CAGR of 12.4%, reaching US$ 3.4 trillion by 2034. This growth trajectory underscores the increasing adoption of renewable energy sources worldwide, propelled by supportive government policies and significant investments in research and development.
Download Sample…
Market Outlook 2032: Latex-saturated Paper to Grow from USD 2.7 Billion to USD 3 …
The global Latex-Saturated Paper Market was valued at US$ 2.7 billion in 2023. It is projected to grow at a CAGR of 3.1% from 2024 to 2032, reaching US$ 3.6 billion by the end of 2032.
Download Sample Report Copy Here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=54201&utm_source=OpenPR_Sandeep&utm_medium=OpenPR
Analyst Viewpoint
The rising demand for durable and water-resistant packaging materials in the food & beverage sector is driving the growth of the latex-saturated paper market. This paper finds applications in…
Hardbanding Services Market Expected to Achieve a 5.8% CAGR, Reaching USD 16.8 B …
The Global Hardbanding Services Market, valued at US$ 9.1 billion in 2023, is estimated to grow at a CAGR of 5.8% from 2024 to 2034, reaching US$ 16.8 billion by the end of 2034.
Download Sample Report Copy Here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84633&utm_source=OpenPR_Sandeep&utm_medium=OpenPR
Analyst Viewpoint
The increasing focus on drill pipe durability is a significant driver for the hardbanding services market. Hardbanding offers excellent abrasion performance under high pressure, providing superior wear-resistant capabilities that protect drill…
More Releases for HIV
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus.
Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral…